MedKoo Cat#: 413069 | Name: Clentiazem (free base)

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Clentiazem (free base) is a calcium channel blocker. It is a chlorine derivative of diltiazem.

Chemical Structure

Clentiazem (free base)
Clentiazem (free base)
CAS#96125-53-0 (free base)

Theoretical Analysis

MedKoo Cat#: 413069

Name: Clentiazem (free base)

CAS#: 96125-53-0 (free base)

Chemical Formula: C22H25ClN2O4S

Exact Mass: 448.1224

Molecular Weight: 448.96

Elemental Analysis: C, 58.86; H, 5.61; Cl, 7.90; N, 6.24; O, 14.25; S, 7.14

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Clentiazem (free base); Clentiazemum
IUPAC/Chemical Name
1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-8-chloro-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, (25-cis)-
InChi Key
GYKFWCDBQAFCLJ-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H25ClN2O4S/c1-14(26)29-20-21(15-5-8-17(28-4)9-6-15)30-19-13-16(23)7-10-18(19)25(22(20)27)12-11-24(2)3/h5-10,13,20-21H,11-12H2,1-4H3
SMILES Code
O=C1C(OC(C)=O)C(C2=CC=C(OC)C=C2)SC3=CC(Cl)=CC=C3N1CCN(C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 448.96 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Dagenais F, Hollmann C, Buluran J, Cartier R. Clentiazem and diltiazem preserve endothelium-dependent relaxation following global rat heart ischemia. Can J Cardiol. 1995 Oct;11(9):816-22. PMID: 7585280. 2: Giasson S, Garceau D, Homsy W, Dumont L. Pharmacodynamics and pharmacokinetics of clentiazem and diltiazem in closed-chest anesthetized dogs. Cardiovasc Drugs Ther. 1995 Oct;9(5):685-92. doi: 10.1007/BF00878551. PMID: 8573551. 3: Vorkapic P, Bevan JA, Bevan RD. Clentiazem protects against chronic cerebral vasospasm in rabbit basilar artery. Stroke. 1991 Nov;22(11):1409-13. doi: 10.1161/01.str.22.11.1409. PMID: 1750049. 4: Deisher TA, Narita H, Zera P, Ginsburg R, Bristow MR, Billingham ME, Fowler MB, Hoffman BB. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats. J Pharmacol Exp Ther. 1993 Jul;266(1):262-9. PMID: 8392553. 5: Miyazaki K, Adaniya H, Sawanobori T, Hiraoka M. Electrophysiological effects of clentiazem, a new Ca2+ antagonist, on rabbit hearts. J Cardiovasc Pharmacol. 1996 May;27(5):615-21. doi: 10.1097/00005344-199605000-00001. PMID: 8859929. 6: Mecca TE, Love SD. Comparative cardiovascular actions of clentiazem, diltiazem, verapamil, nifedipine, and nimodipine in isolated rabbit tissues. J Cardiovasc Pharmacol. 1992 Oct;20(4):678-82. doi: 10.1097/00005344-199210000-00024. PMID: 1280727. 7: Narita H, Zera PH, Ginsburg R. Mechanism of action of clentiazem on human coronary artery and myocardium. Cardiovasc Drugs Ther. 1990 Aug;4(4):1097-104. doi: 10.1007/BF01856505. PMID: 2083194. 8: Fenoy FJ, Milicic I, Mistry M, Mecca TE, Roman RJ. Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive rats. J Pharmacol Exp Ther. 1992 May;261(2):470-5. PMID: 1578362. 9: Shah AK, Bhargava VO, Weir SJ, Giesing DH. Pharmacokinetics of clentiazem after intravenous and oral administration in healthy subjects. J Clin Pharmacol. 1993 Apr;33(4):354-9. doi: 10.1002/j.1552-4604.1993.tb04669.x. PMID: 8473551. 10: Saso Y, Iwasaki H, Yasoshima A, Takashima K, Morita T. Comparison of atherogenicity of soybean oil and peanut oil, and effect of clentiazem on diet- induced atherosclerosis in rabbits. J Vet Med Sci. 1994 Feb;56(1):83-9. doi: 10.1292/jvms.56.83. PMID: 8204766.